Investing

Dryships, Agile Therapeutics in Thursday's 52-Week Low Club

January 5, 2017: Here are four stocks trading with relatively heavy volume among 20 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by about 9 to 7 and on the Nasdaq decliners led advancers by about 3 to 2.

DryShips Inc. (NASDAQ: DRYS) dropped about 14.6% on Thursday to post a new 52-week low of $2.98 against a 52-week high of $278.40 and a Wednesday close of $3.49. Volume of about 17 million was more than double the daily average of around 7.8 million. The dry bulk shipper announced this morning that it plans to buy up to 4 very-large gas carriers at a cost of $83.5 million each.

Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped 9% on Thursday to post a new 52-week low of $3.72 after closing at $4.09 on Wednesday. Volume was more than double the daily average of about 3 million shares. The company had no specific news Thursday.

Express Inc. (NYSE: EXPR) dropped about 6.8% Thursday to post a new 52-week low of $10.07 after closing Wednesday at $10.80. The 52-week high is $21.57. Volume of around 2.7 million was about 15% more than the daily average of around 2.3 million shares traded. The company had no specific news.

Aeterna Zentaris Inc. (NASDAQ: AEZS) dropped about 36% on Thursday to post a new 52-week low of $2.35 after closing at $3.65 on Wednesday. The stock’s 52-week high is $5.59. Volume was about 5 times the daily average of around 430,000 shares. The company said late Wednesday that a clinical trial had failed.

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here
you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.


Click here
to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.